NEW YORK (GenomeWeb) – UgenTec announced today that it has raised $9.3 million in a Series A funding round.

The firm said that it will use the funding to consolidate its position in clinical diagnostics, establish a US office, and enter new diagnostic markets.

"With this financing round, we will consolidate our leading position in clinical diagnostics, set up an office in the United States, and expand into the food safety and quality, agriculture, and animal health [markets]," UgenTec CEO Steven Verhoeven said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.

May
01
Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May
15
Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.